Heim4502 • TYO
add
Takeda Pharmaceutical Co Ltd
Við síðustu lokun
4.119,00 ¥
Dagbil
4.130,00 ¥ - 4.182,00 ¥
Árabil
3.852,00 ¥ - 4.494,00 ¥
Markaðsvirði
6,64 bn JPY
Meðalmagn
3,78 m.
V/H-hlutf.
22,96
A/V-hlutfall
4,60%
Aðalkauphöll
TYO
Í fréttum
BioSpace
fyrir 4 klukkustundum
Takeda Puts Up to $1.3B on the Line for Keros’ Blood Cancer Anemia Drug
0,43%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (JPY) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 1,18 bn | 12,75% |
Rekstrarkostnaður | 540,19 ma. | -10,33% |
Nettótekjur | 92,05 ma. | 291,64% |
Hagnaðarhlutfall | 7,83 | 270,22% |
Hagnaður á hvern hlut | — | — |
EBITDA | 433,99 ma. | 55,12% |
Virkt skatthlutfall | 22,84% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (JPY) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 859,02 ma. | 170,09% |
Heildareignir | 14,57 bn | -2,01% |
Heildarskuldir | 7,65 bn | -1,92% |
Eigið fé alls | 6,92 bn | — |
Útistandandi hlutabréf | 1,59 ma. | — |
Eiginfjárgengi | 0,94 | — |
Arðsemi eigna | 3,92% | — |
Ávöxtun eigin fjár | 4,57% | — |
Peningaflæði
Breyting á handbæru fé
| (JPY) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 92,05 ma. | 291,64% |
Handbært fé frá rekstri | 280,96 ma. | 41,25% |
Reiðufé frá fjárfestingum | -75,13 ma. | -24,02% |
Reiðufé frá fjármögnun | -110,04 ma. | 21,76% |
Breyting á handbæru fé | 54,00 ma. | 3.129,84% |
Frjálst peningaflæði | 97,22 ma. | -39,87% |
Um
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
Framkvæmdastjóri
Stofnsett
12. jún. 1781
Vefsvæði
Starfsfólk
49.281
